In this episode of Medtech Matters, a podcast focused on the medical device manufacturing industry and the factors impacting it, we speak with David Fischel, CEO of Stereotaxis. He explains how his robotic surgical system works and what makes it unique from other systems on the market. He also speaks about the additional benefits that could be realized for interventional technology as a result of his system’s ability to “pull” the catether through the patient’s vasculature. Specifically, the following questions are addressed.

• What type of technology does Stereotaxis offer and what is the target clinical area?
• How does your system improve upon the traditional methods of performing interventional procedures?
• Many of my listeners are familiar with robotic systems as it relates to automation or minimally invasive surgical systems. How does your system compare to the more traditional thought of a robotic system?
• What is the learning curve for doctors seeking to learn how to use your system who are accustomed to more traditional procedures?
• What’s ahead for Stereotaxis? What’s on the horizon?

Listen to this episode and see what you think of the unique robotic surgical system from Stereotaxis. If you’d like to share thoughts, ask questions, or suggest a future participant for Medtech Matters, please reach out to me at sfenske@rodmanmedia.com.

Listen to the podcast streaming via the player or get the podcast on the Medtech Matters channel via your preferred vendor of podcasts, such as Apple Podcasts (iTunes) or Spotify.

Click here to review other podcasts.